Metro International Biotech, LLC
5 clinical trials · Sponsor
◉ Watch Metro International Biotech, LLC
| Record | Firm | Date |
|---|---|---|
| Tracing the Metabolic Flux of Orally Administered NAD+ Precursors (NCT06882096) | Metro International Biotech, LLC | 2025-04-28 |
| Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults (NCT06815991) | Metro International Biotech, LLC | 2025-02-11 |
| Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program (NCT05878119) | Metro International Biotech, LLC | 2023-10-25 |
| Phase 2a MIB-626 vs. Placebo COVID-19 (NCT05038488) | Metro International Biotech, LLC | 2021-10-26 |
| NAD+ Precursor Supplementation in Friedreich's Ataxia (NCT04817111) | Metro International Biotech, LLC | 2021-05-17 |
Track Metro International Biotech, LLC automatically
Every clearance here is in the API, with alerts when new ones post.